Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis

Kluin-Nelemans H. C., Jawhar M., Reiter A., van Anrooij B., Gotlib J., Hartmann K., ...More

THERANOSTICS, vol.11, no.1, pp.292-303, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 11 Issue: 1
  • Publication Date: 2021
  • Doi Number: 10.7150/thno.51872
  • Journal Name: THERANOSTICS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE, MEDLINE, Directory of Open Access Journals
  • Page Numbers: pp.292-303
  • Istanbul University Affiliated: No

Abstract

In systemic mastocytosis (SM), the clinical features and survival vary greatly. Patient-related factors determining the outcome in SM are largely unknown.